How AI is changing diabetes care
人工智慧如何改變糖尿病照護
更新於: 2026年6月7日 上午04:30
Artificial intelligence is fundamentally changing how we manage diabetes, shifting the focus from reactive, periodic check-ins to continuous, personalized support.
人工智慧正從根本上改變我們管理糖尿病的方式，將重點從被動的定期檢查轉移到持續且個人化的支援。
Because diabetes management relies heavily on quantifiable data like blood glucose levels and insulin doses, it is an ideal field for AI innovation.
由於糖尿病管理極度仰賴血糖濃度和胰島素劑量等可量化數據，因此它是人工智慧創新的理想領域。
Technologies like Automated Insulin Delivery (AID) systems act as an artificial pancreas, using algorithms to adjust insulin in real-time, which significantly reduces the mental burden on patients.
自動胰島素輸送（AID）系統等技術扮演著人造胰臟的角色，利用演算法即時調整胰島素，大幅減輕了病患的心理負擔。
Beyond daily management, AI is revolutionizing diagnostics.
除了日常管理外，人工智慧也徹底改變了診斷方式。
Tools can now predict diabetes risk years in advance and detect complications like diabetic retinopathy by analyzing retinal images in minutes.
現在，相關工具能在幾年前就預測糖尿病風險，並透過分析視網膜影像，在幾分鐘內偵測出糖尿病視網膜病變等併發症。
While challenges like the 'black box' problem—where AI decision-making remains opaque—and concerns regarding data privacy and equity persist, the integration of these technologies is essential.
儘管仍存在諸如人工智慧決策過程模糊（亦即「黑箱」問題），以及數據隱私與公平性等疑慮，但整合這些技術仍至關重要。
As the global prevalence of diabetes rises, AI offers a necessary evolution in care, bridging the gap between patient self-management and expert medical guidance to ensure a more efficient and supportive future for patients everywhere.
隨著全球糖尿病盛行率攀升，人工智慧提供了護理領域必要的演進，在病患自主管理與專家醫療指導之間搭起橋樑，確保世界各地的病患擁有更高效且具支援性的未來。
